Ishioka GY - Search Results

1

Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.

Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, del Guercio MF, Oseroff C, Dahlberg C, Alexander J, Chesnut RW, Sette A. Ishioka GY, et al. J Immunol. 1999 Apr 1;162(7):3915-25. J Immunol. 1999. PMID: 10201910

2

A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery.

Alexander J, Oseroff C, Dahlberg C, Qin M, Ishioka G, Beebe M, Fikes J, Newman M, Chesnut RW, Morton PA, Fok K, Appella E, Sette A. Alexander J, et al. J Immunol. 2002 Jun 15;168(12):6189-98. doi: 10.4049/jimmunol.168.12.6189. J Immunol. 2002. PMID: 12055232

3

Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice.

Alexander J, Bilsel P, del Guercio MF, Stewart S, Marinkovic-Petrovic A, Southwood S, Crimi C, Vang L, Walker L, Ishioka G, Chitnis V, Sette A, Assarsson E, Hannaman D, Botten J, Newman MJ. Alexander J, et al. Vaccine. 2010 Jan 8;28(3):664-72. doi: 10.1016/j.vaccine.2009.10.103. Epub 2009 Nov 4. Vaccine. 2010. PMID: 19895924 Free PMC article.

4

Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus.

Alexander J, Bilsel P, del Guercio MF, Marinkovic-Petrovic A, Southwood S, Stewart S, Ishioka G, Kotturi MF, Botten J, Sidney J, Newman M, Sette A. Alexander J, et al. Hum Immunol. 2010 May;71(5):468-74. doi: 10.1016/j.humimm.2010.02.014. Epub 2010 Mar 10. Hum Immunol. 2010. PMID: 20156506 Free PMC article.

5

Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo.

Ishioka GY, Colon S, Miles C, Grey HM, Chesnut RW. Ishioka GY, et al. J Immunol. 1989 Aug 15;143(4):1094-100. J Immunol. 1989. PMID: 2787356

6

Definition of a DQ3.1-specific binding motif.

Sidney J, Oseroff C, del Guercio MF, Southwood S, Krieger JI, Ishioka GY, Sakaguchi K, Appella E, Sette A. Sidney J, et al. Among authors: ishioka gy. J Immunol. 1994 May 1;152(9):4516-25. J Immunol. 1994. PMID: 7512598

7

Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.

Ishioka GY, Adorini L, Guery JC, Gaeta FC, LaFond R, Alexander J, Powell MF, Sette A, Grey HM. Ishioka GY, et al. J Immunol. 1994 May 1;152(9):4310-9. J Immunol. 1994. PMID: 8157954

8

Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide.

Tangri S, Ishioka GY, Huang X, Sidney J, Southwood S, Fikes J, Sette A. Tangri S, et al. Among authors: ishioka gy. J Exp Med. 2001 Sep 17;194(6):833-46. doi: 10.1084/jem.194.6.833. J Exp Med. 2001. PMID: 11560998 Free PMC article.

9

DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles.

Sidney J, Oseroff C, Southwood S, Wall M, Ishioka G, Koning F, Sette A. Sidney J, et al. J Immunol. 1992 Oct 15;149(8):2634-40. J Immunol. 1992. PMID: 1401902

10

The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.

Livingston BD, Crimi C, Grey H, Ishioka G, Chisari FV, Fikes J, Grey H, Chesnut RW, Sette A. Livingston BD, et al. J Immunol. 1997 Aug 1;159(3):1383-92. J Immunol. 1997. PMID: 9233635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters